跳至主要内容
临床试验/NCT06884358
NCT06884358招募中不适用

FunctiOnal caPaciTy Evaluation Using cardIopulMonary Testing and Stress echocArdiography in Anderson-Fabry Disease Patients: OPTIMA-FD Study

IRCCS Policlinico S. Donato8 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年11月13日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
8
主要终点
CPET parameters- peak Vo2

研究概览

简要总结

The goal of this observational study is to observe the relation between excercise parameters - assessed by CPET - and rest/stress hemodynamic parameters - assessed by echocardiogram and CMR - in patients with a genetic diagnosis of Anderson-Fabry Disease.

Participants will undergo:

  • baseline evaluation: clinical evaluation, disease staging with FASTEX and MSSI, KCCQ for quality of life assessment, resting 12-leads ECG, 6MWT, CPET-ESE and contrast-enhanced CMR;
  • before 36 months from baseline: resting 12-leads ECG, 2D rest and stress echocardiogram, CPET-ESE, contrast-enhanced CMR, disease staging with FASTEX and MSSI and KCCQ for quality of life assessment;
  • up to 7 years from baseline: clinical follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with a genetic diagnosis of AFD, according to current guidelines;
  • Informed written consent with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care (for patients age <18 years old, written consent from a caregiver is mandatory).

排除标准

  • eGFR <30 ml/min and other contraindications for CMR (relative controindication: patients with implantable device);
  • Musculoskeletal limitation for exercise test on the cyclo ergometer;
  • Pregnant or breastfeeding women;
  • Any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with a full comprehension of the written consent form.

结局指标

主要结局

CPET parameters- peak Vo2

时间窗: At baseline and before 36 months from baseline.

Peak VO2 ml/Kg/min

CPET parameters- predicted peak Vo2

时间窗: At baseline and before 36 months from baseline.

Predicted peak VO2 (%).

CPET parameters- VE/VCO2 slope

时间窗: At baseline and before 36 months from baseline.

VE/VCO2 slope

CPET parameters- oxygen pulse

时间窗: At baseline and before 36 months from baseline.

02 pulse (ml/beat)

CPET parameters- heart rate during exercise

时间窗: At baseline and before 36 months from baseline.

Heart rate reserve (beats/minute) Heart rate recovery (beat/minute) Heart rate recovery at one minute (beat/minute)

CPET parameters- presence of chronotropic incompetence, O2 pulse flattening and exercise oscillatory ventilation

时间窗: At baseline and before 36 months from baseline.

Chronotropic incompetence (yes/no) 02 pulse flattening (yes/no) exercise oscillatory ventilation (yes/no)

CPET parameters- VO2/work slope

时间窗: At baseline and before 36 months from baseline.

VO2/work slope (ml/min/watt)

Echocardiogram parameters- diastolic function at rest

时间窗: At baseline and before 36 months from baseline.

At rest E/A ratio. At rest mean E/E'. At rest left atrial reservoir function (%). At rest sPAP (mmHg).

Echocardiogram parameters- systolic function of the left and right ventricle at rest

时间窗: At baseline and before 36 months from baseline.

At rest TAPSE (mm) At rest LV ejection fraction (%) At rest LV stroke volume indexed for body mass surface (ml/mq) At rest right ventricular free wall strain (%)

Echocardiogram parameters- right ventricle-pulmonary artery coupling at rest.

时间窗: At baseline and before 36 months from baseline.

At rest TAPSE/sPAP (mm/mmHg)

Echocardiogram parameters- exertional diastolic function

时间窗: At baseline and before 36 months from baseline.

exertional E/A, exertional mean E/E' exertional TAPE/sPAP (mm/mmHg) mPAP/CO (mmHg/L/min)

CMR parameters - LV Mass and LV Max Wall Thickness

时间窗: At baseline and before 36 months from baseline.

LV mass (gr) and LV max wall thickness (mm).

CMR parameters - Systolic Function

时间窗: At baseline and before 36 months from baseline.

Stroke volume indexed to body surface (ml/m2) and left ventricular ejection fraction (%).

CMR parameters - T1 and T2 Mapping

时间窗: At baseline and before 36 months from baseline.

T1 and T2 mapping (msec).

CMR parameters - presence of late gadolinium enhancement

时间窗: At baseline and before 36 months from baseline.

late gadolinium enhancement (yes/no)

CMR parameters - ECV

时间窗: At baseline and before 36 months from baseline.

Extracellular volume (%)

次要结局

  • Incidence of Cardiovascular Events(Up to 7 years follow-up.)

研究者

发起方
IRCCS Policlinico S. Donato
申办方类型
Other
责任方
Principal Investigator
主要研究者

Massimo Piepoli

MD, PhD

IRCCS Policlinico S. Donato

研究点 (8)

Loading locations...

相似试验